• Info
  • Insider Ownership

Insider Trading & Ownership of William Meury

Location
New York, NY
Summary
The estimated net worth of William Meury is at least $4,301,593 dollars as of 02 Jul 2025. William Meury is the Chief Executive Officer, Director, President of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $2.5M. William Meury is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $1.8M.
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow William Meury and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • William Meury has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $4,301,593.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: INCYTE CORP ($2,498,911).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of William Meury

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INCY INCYTE CORP Chief Executive Officer, Director, President $2,498,911 02 Jul 2025
SNDX Syndax Pharmaceuticals Inc Director $1,802,682 05 Feb 2025
KRTX Karuna Therapeutics, Inc. President and CEO, Director $0 18 Mar 2024

Insider Transactions Reported by William Meury:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored